MEDGF Stock: Medacta Group S.A. Stock Price, Analysis & Insights
Get live MEDGF stock price $83.91, comprehensive Medacta Group S.A. stock analysis, charts, news, and expert forecast. Real-time MEDGF stock data and investment insights.
Loading chart data...
Medacta Group S.A. (MEDGF) Overview
Medacta Group S.A. (MEDGF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, MEDGF trades at $83.91 with a market capitalization of 1.67B . Over the past 52 weeks, MEDGF has traded between $83.91 and $83.91 , with the current price positioned at approximately NaN% of this range . The stock currently tra...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 1.67B
- Current price: $83.91
- 52-week range: $83.91 - $83.91
- P/E ratio: 33.30
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced so...
Company Information
- CEO
- Francesco Siccardi
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 1907
Contact Information
- Website
- https://www.medacta.com
- Address
- Strada Regina, 34
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 33.3)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Medacta Group S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Medacta Group S.A.
- ⚠Investors should consider how Medacta Group S.A. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 33.3) requires strong growth to justify
Market Cap
1.67B
P/E Ratio (TTM)
33.30
Beta
1.12
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MEDGF with peer companies:
- Price
- $100.47
- Market cap
- 1.88B
- Price
- $26.00
- Market cap
- 1.33B
- Price
- $14.00
- Market cap
- 997.75M
- Price
- $3.82
- Market cap
- 1.63B
- Price
- $106.48
- Market cap
- 1.84B
- Price
- $5.51
- Market cap
- 1.67B
- Price
- $30.30
- Market cap
- 1.72B
- Price
- $8.95
- Market cap
- 1.13B
- Price
- $11.00
- Market cap
- 1.49B
- Price
- $10.24
- Market cap
- 497.86M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.